9 Publikationen
-
2024 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2987695Krug, David, Vladimirova, Valentina, Untch, Michael, Kühn, Thorsten, Schneeweiss, Andreas, Denkert, Carsten, Ataseven, Beyhan, et al. 2024. “Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy”. Breast 74.
-
2024 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2987540Herold, Natalie, Schmolling, Johanna, Ernst, Corinna, Ataseven, Beyhan, Bluemcke, Britta, Schoemig-Markiefka, Birgid, Heikaus, Sebastian, et al. 2024. “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”. In Abstracts from the 56th European Society of Human Genetics (ESHG) Conference, 32:548. European Journal of Human Genetics . London: Nature.
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2979534Imterat, Majdi, Harter, Philipp, Rhiem, Kerstin, Heitz, Florian, Schneider, Stephanie, Concin, Nicole, Moubarak, Malak, et al. 2023. “Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients”. Cancers 15 (9): 2534.
-
2023 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2985382Slomovitz, B. M., Raaschou-Jensen, N., Coleman, R. L., Gilbert, L., Powell, M. A., Cibula, D., Ghamande, S., et al. 2023. “PFS2 and adjustment of overall survival (OS) for subsequent anticancer therapy in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab plus chemotherapy or chemotherapy alone in the ENGOT-EN3-NSGO/GOG-3031/RUBY trial”. In Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, 34:S514-S515. Annals of Oncology . Amsterdam: Elsevier.
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984317Marme, Frederik, Krieghoff-Henning, Eva, Gerber, Bernd, Schmitt, Max, Zahm, Dirk-Michael, Bauerschlag, Dirk, Forstbauer, Helmut, et al. 2023. “Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images”. European Journal of Cancer 195: 113390.
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2984002Imterat, Majdi, Gebers, Gudrun, Heitz, Florian, Schneider, Stephanie, Ehmann, Sarah, Welz, Julia, du Bois, Andreas, et al. 2023. “Low anterior resection syndrome and its impact on quality of life of ovarian carcinoma patients: A prospective longitudinal study”. Gynecologic Oncology 178: 96-101.
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2984318Bizzarri, Nicolo, Imterat, Majdi, Fruscio, Robert, Giannarelli, Diana, Perrone, Anna Myriam, Mancari, Rosanna, Traut, Alexander, et al. 2023. “Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?”. European Journal of Cancer 195: 113398.
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2980959Herold, Natalie, Schmolling, Johanna, Ernst, Corinna, Ataseven, Beyhan, Blümcke, Britta, Schömig-Markiefka, Birgid, Heikaus, Sebastian, et al. 2023. “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”. Cancer Medicine .
-
2023 | Zeitschriftenaufsatz | E-Veröff. vor dem Druck | PUB-ID: 2979540Inci, Melisa Guelhan, Sehouli, Jalid, Schnura, Eva, Lee, Marlene, Roll, Stephanie, Reinhold, Thomas, Klews, Julia, et al. 2023. “The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design”. International Journal of Gynecological Cancer : ijgc-2023-004531.